TSLP and nasal cavity polyp: Therapeutically, investigation of TSLP inhibitors in non‐Th2 inflammatory phenotypes is warranted given their broad‐spectrum mechanisms might provide novel therapeutic pathways for mixed or neutrophilic chronic rhinosinusitis with nasal polyps.